Market Share of Spain Insulin Drugs And Delivery Devices Industry
The Spanish insulin drug and delivery devices market is moderately consolidated, with a few significant and generic players. Mergers and acquisitions that have happened between the players in the recent past have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance to develop and commercialize Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.
Spain Insulin Drugs And Delivery Devices Market Leaders
-
Eli Lilly
-
Novo Nordisk
-
Sanofi
-
Ypsomed
-
Medtronic
*Disclaimer: Major Players sorted in no particular order
